Adam Whatley, MD
Orthopaedic Surgery · Zachary, LANPI 1518159664
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (56.8%), travel and lodging and speaking fees — rather than concentrated in one kind of arrangement. 27 manufacturers reported payments, led by Stryker at 39.4% of the total. Reporting peaked in 2024 at $3,785 and has fallen 80.1% since, to $753 in 2025.
Across 222 payments — averaging $59.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$5K
- Arthrex$3K
- ALON Medical Technology$2K
- Amgen$722
- Pacira Pharmaceuticals Incorporated$281
- Boston Scientific$271
- plus $2K from 21 others
What the payments were for
- Speaking & faculty fees$2,50019%
- Travel & lodging$3,23124%
- Food & beverage$7,55357%
- Education$210%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker | 71 | $5,243 |
| Arthrex | 20 | $3,452 |
| ALON Medical Technology | 14 | $1,586 |
| Amgen | 56 | $722 |
| Pacira Pharmaceuticals Incorporated | 7 | $281 |
| Boston Scientific | 4 | $271 |
| Johnson & Johnson(2 entities) | 3 | $218 |
| Vericel Corporation | 5 | $188 |
| Medtronic(2 entities) | 4 | $183 |
| Pacira Therapeutics, Inc. | 7 | $143 |
| Bioventus LLC | 4 | $133 |
| Next Science LLC | 1 | $125 |
| Biorez, Inc. | 1 | $120 |
| Zimmer Biomet | 1 | $118 |
| Organogenesis Inc. | 1 | $110 |
| Ferring Pharmaceuticals Inc. | 6 | $102 |
| Kowa Pharmaceuticals America, Inc. | 4 | $64 |
| Smith+Nephew | 3 | $54 |
| Biocomposites Inc | 1 | $43 |
| KCI USA, Inc. | 2 | $33 |
| AbbVie | 1 | $22 |
| Pfizer | 1 | $20 |
| Convatec Inc. | 1 | $19 |
| Axogen | 1 | $17 |
| Sanara Medtech Inc. | 1 | $14 |
| Vertex | 1 | $14 |
| Sanofi-aventis U.S. LLC | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- REUNION$1,746
- MAKO$620
- TRIATHLON$296
- AXSOS$176
- SHOULDER IMPLANTS FIBERTAK KNOTLESS$139
- Intracept$136
- PANGEA$132
- EXTREMITIES & TRAUMA IMPLANTS LONG BONE TRAUMA TROCHANTERIC FRACTURE$131
- SurgX$125
- Xperience$125
- BlastX$125
- BioBrace 23mm$120
- BioBrace 5mm$120
- AccuFill$118
- TFN-Advance$117
- Apligraf$110
- IOVERA SYSTEM$105
- MACI$101
How this compares
$13,306 in reported general payments places this provider in the 75th percentile of 286 orthopaedic surgery providers in Louisiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Celecoxib | 604 | $14,390 |
| Diclofenac Sodium | 228 | $4,151 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 145 | $1,393 |
| Tramadol Hcl | 257 | $725 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 80 | $613 |
| Gabapentin | 53 | $477 |
| Promethazine Hcl | 99 | $340 |
| Amoxicillin | 204 | $233 |
| Meloxicam | 32 | $185 |
| Ibuprofen | 16 | $173 |
| Clindamycin Hcl | 17 | $121 |
| Methylprednisolone | 15 | $96 |
| Mupirocin | 12 | $66 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 13 | $40 |
| Cyclobenzaprine Hcl | 18 | $38 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Zachary
- Christopher HarrodBaton Rouge$3M
- Vinod DasaKenner$1.9M
- Pierce NunleyShreveport$1.8M
- Jorge IsazaBaton Rouge$1.2M
- Neil MakiThibodaux$620K
- Robert ZuraNew Orleans$597K
- Kevin McCarthyBaton Rouge$594K
- Timmothy RandellAlexandria$498K
- Fernando SanchezNew Orleans$484K
- Robert EastonBaton Rouge$394K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.